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OBJECTIVE: We aimed to evaluate whether the inclusion of videothoracoscopy in a pleural empyema treatment
algorithm would change the clinical outcome of such patients.
METHODS: This study performed quality-improvement research. We conducted a retrospective review of patients
who underwent pleural decortication for pleural empyema at our institution from 2002 to 2008. With the old
algorithm (January 2002 to September 2005), open decortication was the procedure of choice, and videothoraco-
scopy was only performed in certain sporadic mid-stage cases. With the new algorithm (October 2005 to December
2008), videothoracoscopy became the first-line treatment option, whereas open decortication was only performed
in patients with a thick pleural peel (.2 cm) observed by chest scan. The patients were divided into an old algorithm
(n=93) and new algorithm (n=113) group and compared. The main outcome variables assessed included treatment
failure (pleural space reintervention or death up to 60 days after medical discharge) and the occurrence of
complications.
RESULTS: Videothoracoscopy and open decortication were performed in 13 and 80 patients from the old algorithm
group and in 81 and 32 patients from the new algorithm group, respectively (p,0.01). The patients in the new
algorithm group were older (41¡1 vs. 46.3¡16.7 years, p=0.014) and had higher Charlson Comorbidity Index scores
[0(0-3) vs. 2(0-4), p=0.032]. The occurrence of treatment failure was similar in both groups (19.35% vs. 24.77%,
p=0.35), although the complication rate was lower in the new algorithm group (48.3% vs. 33.6%, p=0.04).
CONCLUSIONS: The wider use of videothoracoscopy in pleural empyema treatment was associated with fewer
complications and unaltered rates of mortality and reoperation even though more severely ill patients were
subjected to videothoracoscopic surgery.
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INTRODUCTION
Pleural empyema (PE) is a significant clinical condition
with a mortality rate approaching 20% (1). PE treatment
consists of early drainage of the pleural space and the use of
antibiotics (2). Although open thoracotomy is the classical
approach for PE treatment, tube thoracostomy is generally
indicated for patients with early-stage empyema, whereas
patients with pleural loculations or a trapped lung should
ideally undergo pleural decortication (1,2). More recently,
however, video-assisted thoracic surgery (VATS) has
become an attractive alternative, as many authors claim
that this technique serves as a minimally invasive procedure
to provide reduced morbidity and postoperative pain,
improved cosmetics and fewer complications (3,4).
Previous case series have compared the use of VATS with
that of traditional open decortication (OD) head-to-head (5-
15)for PE treatment. These comparative studies demon-
strated the usefulness of VATS and its advantages related
to shorter postoperative hospital and intensive care unit
(ICU) stays (5,7,8,11-14), less intense postoperative pain
(9,11,12) and reduced morbidity (6,8,11-13). Such studies
have also suggested that videothoracoscopy should replace
open decortication in most situations and that it should be
emphasized in the PE management algorithm. Nonetheless,
the question as to whether the wider use of VATS would
improve clinical outcomes in daily practice remains unan-
swered. Therefore, the purpose of the present study was to
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557evaluate whether the implementation of VATS as part of a PE
treatmentalgorithmwould alter theclinicaloutcomes of such
patients in routine clinical care.
MATERIALS AND METHODS
This study implemented quality-improvement research
and conducted a retrospective study that compared the
effects of PE treatments performed during two different
periods of time. During the first period (January 2002 -
September 2005), we used an algorithm to treat PE in which
patients preferably underwent OD. Then, in 2005, our
division acquired a dedicated video system, and we
changed our protocol. During this second period (October
2005 - December 2008), a new algorithm was used that
included VATS as the procedure of choice.
We sought to include all consecutive patients who
underwent PE surgical treatment from January 2002 to
December 2008 at the Division of Thoracic Surgery of
Clinics Hospital at the University of Sa ˜o Paulo Medical
School. We reviewed the records of our division using the
terms pleural empyema, parapneumonic effusion, pleural dec-
ortication, thoracotomy and video-assisted thoracic surgery and
retrieved a total of 234 patients. The charts of these patients
were recovered. The exclusion criteria included a complete
absence of data in a patient’s charts and equivocal inclusion
in the records of our division (misclassification). Patients
who underwent open thoracostomy but not VATS or OD
were not included in this study. The study protocol was
reviewed and approved by the local institutional ethics
committee (CAPPesq number 0422/10).
Treatment algorithms
The management of patients with suspected pleural
infection or disease at our institution was performed in
accordance with the Brazilian Guidelines for Pleural
Empyema Management (16), which are similar to the
British Thoracic Society guidelines for the management of
pleural infection (17). Briefly, patients with a pleural
effusion demonstrating purulent fluid or aglucose level
,40 mg/dL, lactate dehydrogenase level.1,000 IU/L, or
positive Gram stain or culture were selected to undergo
thoracostomy tube drainage and an intravenous antibiotics
regimen. In addition, patients whose chest computed
tomography (CT) scans or ultrasonography results sug-
gested loculated pleural effusion, as well as those whose
previous treatment with a chest tube had failed, were
selected to receive pleural decortication. This treatment
algorithm was strictly adhered to by the surgeons of our
department, such that patient selection for operative
procedures was standardized and homogeneous through-
out the study period.
This study involved a comparison between two time
periods, during which different algorithms were used to
treat PE. During the first period, which ranged from January
2002 to September 2005, the algorithm (termed old algorithm)
considered OD to be the procedure of choice for pleural
decortication due to PE. Patients exhibiting significant
medical comorbidities that resultedin a prohibitively high-
operative risk received open thoracostomy (18) and were
not included in this study. During this first period, VATS
was only performed in a few sporadic, randomly selected
mid-stage cases, as the surgical team was constrained by
video system availability.
In 2005, our division acquired an exclusive video system,
which provided the opportunity to fully incorporate VATS
as part of the PE treatment algorithm. In this second period,
ranging from October 2005 to December 2008, the algorithm
(termed new algorithm) considered VATS to be the proce-
dure of choice, and our team resorted to OD only for
patients with a very thick pleural peel (.2 cm), as observed
by CT scan. The indications for open thoracostomy
remained the same as those during the first period of the
study.
Surgical techniques
The entire patient series was operated on under general
anesthesia, using a double-lumen tube for selective ventila-
tion. For the patients undergoing OD, the thorax was
approached via standard lateral thoracotomy. After debri-
dement was accomplished, one or two chest tubes (28F)
were inserted into the lower part of the cavity through
separate incisions. For patients receiving the VATS
approach, we routinely administered a 2-cm high incision
(fourth or fifth intercostal space) to enable proper visual
cavity exploration. A 10-mm trocar was inserted following
digital exploration. By direct visualization, two more
incisions were made in the fifth and eighth intercostal
spaces. The videothoracoscope and the trocar were then
moved to the lower incision. Additionally, as much of the
visceral and parietal pleural peel was removed as possible
to perform decortication. The procedure was converted to
OD if adequate decortication was not achieved or if
complications occurred that could not be approached by
VATS. After the lung was sufficiently reexpanded and
examined for air leakage, one or two chest tubes (28F) were
placed anteriorly or posteriorly under direct videothoraco-
scopic vision.
The patients were sent either to the ICU or to the ward,
depending on their degree of illness and performance
status; however, the OD or VATS approach itself was not
considered to be an ICU indication. Antibiotic therapy
continued postoperatively, as guided by the microbiologic
analysis of intraoperative specimens. Pain management (19)
and respiratory therapy (20) were standardized and
delivered in a homogeneous fashion throughout the study.
Chest radiographs were obtained at the first postoperative
day, following chest tube removal and subsequently
depending on the clinical course of each patient prior to
medical discharge. The chest tubes were removed only after
the cessation of air leakage or daily drainage of less than
200 ml of serous fluid. Prolonged air leakage was dealt with
by attaching a Heimlich valve, whichenabled outpatient
follow-up.
As previously mentioned, VATS became the procedure of
choice for PE treatment during the seven-year study period.
Throughout this period, minor changes were also made
regarding antibiotic therapy and intensive care. However,
the pain management and respiratory therapy protocols did
not change significantly.
Data collection
Patient data were retrospectively collected from the patient
charts for the current study, and the following patient
information was obtained: age; gender; length of preopera-
tive hospital stay (time spent between the first day of
hospitalization and the surgical procedure); preoperative
thoracostomy tube drainage; type of surgical treatment
Videothoracoscopy in Pleural Empyema Treatment
Terra RM et al.
CLINICS 2012;67(6):557-563
558(VATS or OD); PE etiology; time spent in surgery (including
in-room anesthesia time, surgical procedure time and in-
room anesthesia recovery time); length of postoperative
hospital stay; postoperative chest tube time (defined as when
the chest tube was removed); length of postoperative ICU
stay; and the occurrence of complications, reinterventions in
the pleural space and mortality (in-hospital deaths and those
within 60 days of medical discharge).
Outcomes
The two main outcomes evaluated were failure of the
surgical therapy and the occurrence of complications.
Treatment failure was defined as the occurrence of
reintervention in the pleural space (i.e., reinsertion of the
chest tube, open thoracostomy or redecortication) or death
(in-hospital deaths and those within two months of hospital
discharge). The incidence of complications was thoroughly
investigated using the available patient charts, particularly
those previously identified as demonstrating intraoperative
bleeding (requiring blood transfusion), deep vein thrombo-
sis, pulmonary embolism, prolonged air leakage (.seven-
days), cardiac arrhythmia, subcutaneous emphysema,
surgical wound infection or seroma and bronchopneumonia
(defined as a lung infection that developed into non-
pneumonic PE or moved to the contralateral lung).
The following variables were also analyzed to assess the
overall effectiveness of the strategies employed during both
time periods: postoperative hospital stay, thoracostomy
tube drainage time and ICU stay.
Data analysis
The studied patients were divided into the following two
groups, according to the algorithm used to define their
surgical procedure: the OA (old algorithm) and NA (new
algorithm) groups.
Statistical significance was set at 0.05. For qualitative
variables, Fisher’s exact test or the Chi-square test was used
as appropriate. For quantitative variables, the Mann-
Whitney U test was used for non-parametric variables,
whereas the non-paired Student’s t-test was used for
parametric variables. Potential outcome predictive factors
were evaluated using a univariate analysis. Those factors
with p-values,0.1 were included in the multivariate
analysis to compose a logistic regression model. All of the
tests were performed using the StataH Inc. software, version
11, 2009.
RESULTS
A total of 234 patients were identified from the records of
the thoracic surgery division at our institution, but only 206
of these cases were selected for the current study. The flow
chart shown in Figure 1 depicts the reasons for patient
exclusion at all stages of the study, the methods used for
group division and the main outcome results.
The characteristics of the patients included in the study
are presented in Table 1. Parapneumonic PE was the most
frequent type of PE etiology (n=131), and community-
acquired pneumonia accounted for 72.5% (n=95) of such
Figure 1 - Patient flow and the main results obtained. *, only the percentage of cases with at least one complication was statistically
significant (p=0.04).
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559cases. Similar rates were found in both patient groups (OA
Group: 42 patients, 73.6% vs. NA group: 53 patients, 71.6%).
The patients in the NA group were older and had signi-
ficantly higher ASA-PS (American Society of Anesthesio-
logists Physical Status) (21) and Charlson Comorbidity
Index (CCI) (22) scores than the patients in the OA group.
As expected, OD was more common in the OA group,
whereas the use of VATS predominated in the NA group.
The distribution of these procedures within the examined
time period is shown in Figure 2.
Pleural liquid bacterioscopic results were obtained in
94.67% (n=192) of the patients, and these results tested
positive in 30.21% of such cases (n=58). These results
revealed Gram-positive bacteria in 26.04% (n=50) of the
cases and Gram-negative bacteria in 8.85% (n=17). Pleural
liquid culture results were obtained in 95.15% of patients
(n=196), and these results tested positive in 44.38% of such
cases (n=87). The most frequently identified bacterium was
Staphylococcus aureus (17.85%, n=35). Anaerobic microor-
ganisms were identified in 6.63% (n=13) of the patients, and
Table 1 - Total sample and group characteristics.
Variable Total OA Group NA Group p-value
No. patients 206 93 113
Gender (M/F) 150/56 67/26 83/30 0.94
Age (years) 44.1¡16.8 41¡17 46.3¡16.7 0.014
Etiology (n)
Parapneumonic 131 (63.5%) 57 (61.2%) 74 (65.4%)
Post-Thoracic Procedures* 24 (11.6%) 9 (9.6%) 15 (13.2%)
Tuberculous 24 (11.6%) 12 (12.9%) 12 (10.6%)
Infected Hemothorax
+ 20 (9.7%) 12 (12.9%) 8 (7.1%)
Subphrenic abscess{ 5 (2.42%) 2 (2.1%) 3 (2.6%)
Unknown 2 (0.9%) 1 (0.1%) 1 (0.8%)
Hemithorax (R/L/Bilat) 120/82/4 51/40/2 69/42/2 0.66
Preoperative hospital stay (days) 14.8¡19.2 15.1¡17.9 14.6¡20.4 0.85
Previous Chest Tube 92 (44.6%) 44 (47.3%) 48 (42.4%) 0.24
Preoperative drainage time (days) 12.8¡10.3 11¡7.3 14¡11.9 0.28
ASA-PS (p25-p75) 2 (2-3) 2 (1-3) 2 (2-3) 0.013
CCI (p25-p75) 1 (0-4) 0 (0-3) 2 (0-4) 0.032
OD/VATS 112/94 80/13 32/81 ,0.001
The data are presented as either n(%), median ¡ standard deviation or p50 (p25-p75). OA, old algorithm; NA, new algorithm; M, male; F, female; R, right;
L, left; Bilat, bilateral; ASA-PS, American Society of Anesthesiologists Physical Status; CCI, Charlson Comorbidity Index; OD, open decortication; VATS,
Video-Assisted Thoracic Surgery; *, thoracic procedures included: pulmonary lobectomy (n=7), pleurodesis (n=5) and others (n=9);
+, causes included
thoracic trauma (n=15) and others (n=5); {, causes included hepatic abscess (n=4) and pancreatic-pleural fistula (n=1).
Figure 2 - Use of video-assisted thoracoscopic surgery (VATS) and open decortication (OD) for cases of pleural empyema according to
year of the study. Each bar represents the relative percentage of cases performed using the VATS approach (white bar) or the open
approach (black bar). It is noteworthy that the number of VATS cases performed tended to increase over time, whereas those using OD
demonstrated a steady decline.
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560Streptococcus pneumoniae was identified in 0.51% of the cases
(n=1). No significant difference was observed between the
groups regarding these microbiological results.
The variables considered for the determination of treat-
ment efficacy are presented in Table 2. The treatment failure
rates were similar in both groups, and no significant results
were found when the groups were adjusted for age and the
presence of comorbidities. All of the deaths occurred in-
hospital, as none occurred after patient discharge. The
causes for patient death and pleural space reintervention
procedures are listed in Table 3. A higher complication rate
was observed among the patients in the OA group. Even
after excluding intraoperative blood transfusion as a
complication, this rate remained significantly higher among
the patients in the OA group (24.73% vs. 14.15%, p=0.02).
The patients in the NA group experienced longer post-
operative ICU stays (p=0.045) and tended to have greater
postoperative thoracostomy tube drainage times (p=0.09).
Overall, the OD conversion rate was 2.91% (n=6), as
observed in the NA group. The causes for conversion
included inadequate lung reexpansion that required further
decortication in five cases and accidental diaphragmatic
injury in one patient. In addition, one patient experienced
an intraoperative diaphragmatic injury that was able to be
fixed without conversion.
After performing aunivariate and logistic regression
analysis including all of the significant predictors, only CCI
was shown to correlate with both treatment failure (Odds
Ratio=1.26,95%ConfidenceInterval:1.08-1.47, p=0.003)and
death (Odds Ratio=1.202, 95% Confidence Interval: 1.04-
1.37, p=0.008). In addition, chest tube insertion prior to the
surgical procedure correlated with pleural space reinterven-
tion performance (Odds Ratio=2.96, p=0.03).
DISCUSSION
In this study, the implementation of VATS as the
procedure of choice in the PE management algorithm did
not change the overall outcome of patients in a tertiary
care facility, and the mortality and reintervention rates were
Table 2 - Variables defining treatment efficacy.
Variable
Total
(n=206) OA Group (n=93) NA Group (n=113) p-value
Treatment Failure 46 (22.3%) 18 (19.3%) 28 (24.7%) 0.35
Patient Death 31 (15.1%) 13 (13.9%) 18 (15.9%)
Pleural Space Reintervention 19 (9.2%) 6 (6.45%) 13 (11.5%)
Cases with complications* 83 (40.2%) 45 (48.3%) 38 (33.6%) 0.04
Total number of complications 110 60 50
Intraoperative blood transfusion 63 34 29
DVT 41 3
Prolonged air leak 13 6 7
Chylothorax 10 1
Diaphragmatic lesion 20 2
High Response Atrial Fibrillation 11 0
Bronchopneumonia 11 10 1
Surgical Wound Infection 73 4
Seroma 22 0
Subcutaneous Emphysema 63 3
Operation Room time (min)
+ 200.8¡87 198.6¡82.6 202.7¡90.8 0.74
ICU postoperative stay (days) 1 (0-2) 1 (0-2) 1 (0-3) 0.045
Thoracostomy tube drainage (days) 6 (5-11) 6 (5-8) 7 (5-14) 0.09
Postoperative hospital stay (days) 9 (7-16) 8 (7-14) 10 (7-19) 0.14
The data are presented as either n (%), median ¡ standard deviation or p50 (p25-p75). OA, old algorithm; NA, new algorithm; ICU, intensive care unit;
DVT, deep vein thrombosis; *, number of patients with at least one complication;
?time spent between the patient’s entrance to and exit from the surgical
room.
Table 3 - Causes of death and new pleural procedures performed as reinterventions.
Variable
Total
(n=206) OA Group (n=93) NA Group (n=113) p-value
Patient Death 31 (15.1%) 13 (13.9%) 18 (15.9%) 0.69
Multiple Organ Failure 25 12 13
Respiratory Insufficiency 211
Non-pulmonary cause 404
Postoperative Day Death 13 (8.5-29) 11 (9-14) 18.5 (8.5-33.5)
Pleural Space Reintervention 19 (9.2%) 6 (6.4%) 13 (11.5%) 0.21
Chest tube 615
Open Thoracostomy 642
Decortication
VATS 202
OD 514
Postoperative Day Reintervention 23 (18.2-36.7) 30 (21.5-54.2) 22.5 (18-33.2)
The data are presented as either n (%) or p50 (25-75). OA, old algorithm; NA, new algorithm; VATS, Video-Assisted Thoracic Surgery; OD, open
decortication.
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561similar for both algorithms. Nonetheless, during the second
time period, the complication rate decreased significantly
even though the profile of the patients undergoing pleural
decortication had changed, as older and more debilitated
patients (according to the ASA and Charlson Comorbidity
Index values) were operated on during this time. These
patient differences maybe explained by the fact that the
clinicians felt more confident sending severely impaired
patients to receive a minimally invasive procedure than an
open surgery.
Several of the results obtained in this study were outside
of the ranges commonly reported in previous case series.
First, the mortality rate of 15.04% identified in the current
study was higher than the typical range from 0 to 3.32 % (5-
7,9,11,14). We ascribe this finding to the following factors: a)
the characteristics of our population, as there were a greater
number of comorbidities and cases proceeding from the
ICU; b) the inclusion of patients with PE of an etiology other
than parapneumonic, notably post-thoracic procedures
(11.6%) and tuberculosis (11.6%) empyemas; c) the presence
of patients with malignant pleural effusions, for whom it is
significantly more difficult to achieve full lung expansion
(23,24); and d) the definition of mortality as in-hospital
death or with 60 days after medical discharge, compared
with perioperative death,which has been commonly used in
other case series (5,6,8,9,11,12,14). For the MIST-1 trial,
Maskell et al. used similar outcome definitions and reported
similar empyema-related mortality rates (14.5% at three
months) (25). Second, the overall rate of cases presenting at
least one complication was 40.2%, which was higher than
the typical range reported in the literature (11 to 25%) (10-
12). Again, this discrepancy was likely related to the specific
definitions used. Similarly to previous studies (13), we
considered intraoperative blood transfusion to be a compli-
cation, as it is often a surrogate for intraoperative bleeding.
Furthermore, blood transfusions correlate with procedure
morbidity, involve potential intrinsic complications and
increase the financial cost of the surgical procedure.
Ultimately, blood transfusions accounted for 57.27% of all
of the complications identified, whereas the most frequent
complication in previous series was prolonged air leakage
(11). However, as shown previously in the literature (6,8,11-
13), the implementation of VATS led to fewer complications;
even after excluding blood transfusion as a potential
complication, the difference between the groups remained
significant, and the overall complication rate was 18.93%.
Finally, the microbiological findings of the current study
were particularly intriguing. Not only was the pleural fluid
culture positivity lower than those reported in other series
(44.38% vs. 53.95 - 76.1%) (8,25) but the culture profiles were
also quite unusual. For example, S. pneumoniae was
identified in only one case, although it has been commonly
referred as an important etiological agent [present in 8.37 -
14.95% of cases] (8,25), and S. aureus was the most frequent
bacterial strain isolated in our series. These facts may reflect
the large number of ICU patients in our study and the
effects of early antibiotic use.
Previous studies have extensively described the advan-
tages of VATS over OD, which include shorter post-
operative hospital stays (5,7,8,11-14), a more rapid return
to work (11), reduced thoracostomy tube drainage time
(6,11-13), decreased surgical time (6,7,9,11-13), less perio-
perative pain (9,11,12), a reduced complication rate (6,8,11-
13), decreased postoperative air leakage (11,13) and reduced
mortality (8,13). Therefore, we had hypothesized that there
would have been improvements in the measured outcomes
of PE treatment after the implementation of VATS as a
standard procedure, but only the complication rates were
shown to improve. Apart from the outcome definition issue,
the following reasons may serve to explain our findings.
First, our study represented a standard clinical practice
scenario (outcomes assessment study), in which the results
were influenced by several unknown confounders. Second,
during the second period, more severely affected patients
were operated on, which may have masked the advantages
of the VATS method.
Among our results, one unexpected finding was the
longer postoperative ICU stays during the second period.
Older age and a greater number of comorbidities may have
lengthened the time spent in the ICU for these patients even
though they had fewer postoperative complications than the
patients in the OA group. Another surprising finding was
the reintervention rate associated with the NA group,
which, although not significant, was substantially higher
than that observed in the OA group. However, the
reintervention rate of the NA group rate may have been
overestimated because, at the beginning of the wider use of
VATS, the surgeons were not as confident with this method
and were more prone to perform additional procedures in
such patients. In support of this assumption is the fact that,
during the second period, chest tube insertion (a minor
procedure) was the most frequent pleural reintervention,
whereas open thoracostomy was the most frequent type of
reintervention during the first period. In our division, open
thoracostomy is considered to represent the last resort for
empyema management. Alternatively, the greater reinter-
vention rate during the second period may have been
associated with incomplete decortications, which could also
explain the longer chest tube duration recorded for the NA
group. Furthermore, the VATS learning curve could also
have influenced this higher reintervention rate, although the
year in which VATS was performed did not correlate with
the complication rate in the multivariate analysis.
The results presented in this study can be further
generalized for other teaching tertiary care institutions.
The management of PE in our facility follows international
guidelines, and the study population included all of the
patients operated on during the study period (excluding the
few patients whose medical charts could not be found).
Therefore, our results reflect standard daily clinical practice,
which is why we opted to include all consecutive PE cases,
including those with different etiologies. However, the
major threat to the generalization of these results is the fact
that, due to particular features of the Brazilian public health
system, many patients experience a lengthy preoperative
time between their first admission to a health care facility
and definitive surgical treatment. Referrals to a tertiary
institution generally occur late in the context of this study,
and this situation may be different at other facilities
worldwide.
The main limitation of this study, apart from its retro-
spective design, was the potential bias associated with the
analysis of different periods of time. To minimize this bias,
we evaluated a period of only three years before and after
the introduction of VATS. Moreover, no major changes to
our postoperative care occurred throughout the study.The
pain and respiratory therapy protocols were standardized
prior to the period evaluated and, most importantly, the
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562indications for surgical referral remained constant during
the study period. Nevertheless, minor changes in antibiotic
therapy and certain ICU routines occurred during the study
period. In addition, the patients studied had been operated
on by more than one surgeon, which may have interfered
with our results. Finally, although the PE treatment
algorithm was changed in 2005, we implemented this
change gradually, as depicted in Figure 2, which could
have led us to underestimate the potential differences
between the two algorithms.
In conclusion, the incorporation of VATS into the
algorithm for the treatment of PE did not significantly
change the mortality or reoperation rates of the patients at
our tertiary care hospital. Nevertheless, the more wide-
spread use of VATS correlated with fewer postoperative
complications and likely caused clinicians to send more
severely ill patients to receive surgery.
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